Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hydralazine vs. Labetalol for the Management of Hypertensive Crisis in Patients With Hypertensive Disorders of Pregnancy. A Randomized Controlled Trial.

NCT01538875 is registered in ClinicalTrials.gov with Saint Thomas Hospital, Panama as lead sponsor.

NCT NCT01538875
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01538875 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hydralazine vs. Labetalol for the Management of Hypertensive Crisis in Patients With Hypertensive Disorders of Pregnancy. A Randomized Controlled Trial.
Lead sponsor
Saint Thomas Hospital, Panama
Phase
Phase 3
Overall status
Completed
Start date
July 31, 2012
Completion date
May 31, 2013
Enrollment
261 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension, pregnancy induced